Mount Sinai Cardiologists Recognized With American College of Cardiology Top Honor
Roxana Mehran, MD, FACC, Director of Interventional Cardiovascular Research and Clinical Trials and George Dangas, MD, PhD, FACC, Director of Cardiovascular Innovation, both at the Icahn School of Medicine at Mount Sinai, were honored for their invaluable contributions to the cardiovascular profession on March 19 during the American College of Cardiology’s (ACC) 66th Annual Scientific Session in Washington.
Dr. Mehran received the 2017 Bernadine Healy Leadership in Women’s CV Disease Award presented to a Fellow of the ACC who has demonstrated leadership and accomplishment in the field of cardiovascular disease in women exemplified by research, teaching, practice or service. Dr. Dangas received the 2017 Distinguished Teacher Award presented to a Fellow of the ACC who has demonstrated innovative, outstanding teaching characteristics and compassionate qualities and because of these attributes has made major contributions to the field of cardiovascular medicine at the national and/or international level.
Eighteen Distinguished Awards were presented at the Annual Scientific Session this year, each recognizing an individual who has made outstanding contributions to the field of cardiovascular medicine. Recipients were nominated by their peers and then selected by the ACC Awards Committee.
Dr. Mehran is internationally recognized her work as a clinical trial specialist with complex data analyses and outcomes research in the field of interventional cardiology and for her experience in working with regulatory agencies to conduct clinical trials. Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients and include advancing treatments for acute coronary syndromes and acute myocardial infarction.
Dr. Dangas is a leading authority in the performance of nonsurgical cardiac and vascular interventions (e.g. stent, angioplasty, atherectomy) using both established and novel techniques and in preventing and dissolving thrombosis in the coronary and peripheral arteries. He is currently serving as the Chair of the American College of Cardiology Interventional Scientific Council and has been a Trustee of the Society for Cardiovascular Angiography & Interventions (SCAI).
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.
The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the "Honor Roll" of best hospitals in America, ranked No. 15 nationally in the 2016-2017 "Best Hospitals" issue of U.S. News & World Report. The Mount Sinai Hospital is also ranked as one of the nation's top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai West are ranked regionally. Mount Sinai's Kravis Children's Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in "Best Children's Hospitals."